Potent Pure β-NMN Trusted by Consumers
UTHEVER® from EffePharm is a powerful NAD+ precursor that has been extensively researched in both human and animal scientific studies, with over 20 publications validating its efficacy. Some of the best studied areas are its use in anti-ageing, skin health, gut health, sports performance, pneumonia and rare diseases. The health benefits in these areas are observed in children and adults, under health conditions and various medical conditions.

Uthever® is the world’s first NMN brand to conduct large-scale clinical study.

The influence of UTHEVER® NMN extends far beyond its anti-ageing properties, as substantiated by eight scientific research studies. The below findings suggest that UTHEVER® NMN has the potential to offer significant benefits to consumers who experience various health issues, including but not limited to:
UVB-Induced Skin Damage, Hair Loss
Pneumonia, Intestinal Damage, Stress-induced Enteritis
MELAS Syndrome, Autism
We are among the few NMN manufacturers on the market to achieve a full conversion rate and produce 100% β-NMN solely, which means no wasteful inert α-NMN to be thrown away, no solvent, and no hazardous impurities. Remember, only β-NMN Works.
100 %
conversion rate across all Uthever® product lines
99.99 %
fully recyclable production residues

The life-cycle transparency allows us to share a visible supply chain of UTHEVER® NMN. From the original biological synthesis R&D to the “final place of manufacturing” where the ingredient is tested and finally processed for sale, the UTHEVER® traceability promise affirms product authenticity and consumer confidence.

UTHEVER® NMN keeps pace with developments in health and well-being. We continually develop new formulations and ingredient applications to meet changing consumer preferences and customer needs.

Low Density
0.18-0.2 g/ml
Powder Formulation
High Density
0.3 – 0.5 g/ml
Capsules and Tablets Formulation
Ultra-High Density
0.6-0.8 g/ml
Bigger Dosage
Capsules or Tablets Formulation
Your success, our priority. At UTHEVER®, we pride ourselves on being highly responsive to our client’s requests, ensuring swift and efficient action. Experience swift and attentive service with solutions tailored precisely to your needs. Contact us now and see hoAw we collaborate to bring your vision to life.

Huang, H. (2022). A multicentre, randomised, double blind, parallel design, placebo controlled study to evaluate the efficacy and safety of uthever (NMN supplement), an orally administered supplementation in middle aged and older adults. Frontiers in Aging, 3. https://doi.org/10.3389/fragi.2022.851698